Global Central Nervous System Disorders Therapeutics Market Size, Status and Forecast 2020-2026

May 2020 | 93 pages | ID: G95BD9CC7877EN
QYResearch

Abstracts

This report focuses on the global Central Nervous System Disorders Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Central Nervous System Disorders Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• Eli Lilly
• GlaxoSmithKline
• Janssen Pharmaceuticals
• Novartis
• Pfizer
• ...

Market segment by Type, the product can be split into

• Depression
• MS
• bipolar disorder
• schizophrenia
• epilepsy
• AD
• Parkinson' s
• others

Market segment by Application, split into

• Clinicals
• Hospitials

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Central Nervous System Disorders Therapeutics status, future forecast, growth opportunity, key market and key players.
• To present the Central Nervous System Disorders Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Central Nervous System Disorders Therapeutics are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Central Nervous System Disorders Therapeutics Revenue
1.4 Market Analysis by Type
  1.4.1 Global Central Nervous System Disorders Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Depression
  1.4.3 MS
  1.4.4 bipolar disorder
  1.4.5 schizophrenia
  1.4.6 epilepsy
  1.4.7 AD
  1.4.8 Parkinson' s
  1.4.9 others
1.5 Market by Application
  1.5.1 Global Central Nervous System Disorders Therapeutics Market Share by Application: 2020 VS 2026
  1.5.2 Clinicals
  1.5.3 Hospitials
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Central Nervous System Disorders Therapeutics Market Perspective (2015-2026)
2.2 Central Nervous System Disorders Therapeutics Growth Trends by Regions
  2.2.1 Central Nervous System Disorders Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Central Nervous System Disorders Therapeutics Historic Market Share by Regions (2015-2020)
  2.2.3 Central Nervous System Disorders Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Central Nervous System Disorders Therapeutics Market Growth Strategy
  2.3.6 Primary Interviews with Key Central Nervous System Disorders Therapeutics Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Central Nervous System Disorders Therapeutics Players by Market Size
  3.1.1 Global Top Central Nervous System Disorders Therapeutics Players by Revenue (2015-2020)
  3.1.2 Global Central Nervous System Disorders Therapeutics Revenue Market Share by Players (2015-2020)
  3.1.3 Global Central Nervous System Disorders Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Central Nervous System Disorders Therapeutics Market Concentration Ratio
  3.2.1 Global Central Nervous System Disorders Therapeutics Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Central Nervous System Disorders Therapeutics Revenue in 2019
3.3 Central Nervous System Disorders Therapeutics Key Players Head office and Area Served
3.4 Key Players Central Nervous System Disorders Therapeutics Product Solution and Service
3.5 Date of Enter into Central Nervous System Disorders Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Central Nervous System Disorders Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Central Nervous System Disorders Therapeutics Forecasted Market Size by Type (2021-2026)

5 CENTRAL NERVOUS SYSTEM DISORDERS THERAPEUTICS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Central Nervous System Disorders Therapeutics Market Size by Application (2015-2020)
5.2 Global Central Nervous System Disorders Therapeutics Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Central Nervous System Disorders Therapeutics Market Size (2015-2020)
6.2 Central Nervous System Disorders Therapeutics Key Players in North America (2019-2020)
6.3 North America Central Nervous System Disorders Therapeutics Market Size by Type (2015-2020)
6.4 North America Central Nervous System Disorders Therapeutics Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Central Nervous System Disorders Therapeutics Market Size (2015-2020)
7.2 Central Nervous System Disorders Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Central Nervous System Disorders Therapeutics Market Size by Type (2015-2020)
7.4 Europe Central Nervous System Disorders Therapeutics Market Size by Application (2015-2020)

8 CHINA

8.1 China Central Nervous System Disorders Therapeutics Market Size (2015-2020)
8.2 Central Nervous System Disorders Therapeutics Key Players in China (2019-2020)
8.3 China Central Nervous System Disorders Therapeutics Market Size by Type (2015-2020)
8.4 China Central Nervous System Disorders Therapeutics Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Central Nervous System Disorders Therapeutics Market Size (2015-2020)
9.2 Central Nervous System Disorders Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Central Nervous System Disorders Therapeutics Market Size by Type (2015-2020)
9.4 Japan Central Nervous System Disorders Therapeutics Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Central Nervous System Disorders Therapeutics Market Size (2015-2020)
10.2 Central Nervous System Disorders Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Central Nervous System Disorders Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Central Nervous System Disorders Therapeutics Market Size by Application (2015-2020)

11 INDIA

11.1 India Central Nervous System Disorders Therapeutics Market Size (2015-2020)
11.2 Central Nervous System Disorders Therapeutics Key Players in India (2019-2020)
11.3 India Central Nervous System Disorders Therapeutics Market Size by Type (2015-2020)
11.4 India Central Nervous System Disorders Therapeutics Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Central Nervous System Disorders Therapeutics Market Size (2015-2020)
12.2 Central Nervous System Disorders Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Central Nervous System Disorders Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Central Nervous System Disorders Therapeutics Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Eli Lilly
  13.1.1 Eli Lilly Company Details
  13.1.2 Eli Lilly Business Overview and Its Total Revenue
  13.1.3 Eli Lilly Central Nervous System Disorders Therapeutics Introduction
  13.1.4 Eli Lilly Revenue in Central Nervous System Disorders Therapeutics Business (2015-2020))
  13.1.5 Eli Lilly Recent Development
13.2 GlaxoSmithKline
  13.2.1 GlaxoSmithKline Company Details
  13.2.2 GlaxoSmithKline Business Overview and Its Total Revenue
  13.2.3 GlaxoSmithKline Central Nervous System Disorders Therapeutics Introduction
  13.2.4 GlaxoSmithKline Revenue in Central Nervous System Disorders Therapeutics Business (2015-2020)
  13.2.5 GlaxoSmithKline Recent Development
13.3 Janssen Pharmaceuticals
  13.3.1 Janssen Pharmaceuticals Company Details
  13.3.2 Janssen Pharmaceuticals Business Overview and Its Total Revenue
  13.3.3 Janssen Pharmaceuticals Central Nervous System Disorders Therapeutics Introduction
  13.3.4 Janssen Pharmaceuticals Revenue in Central Nervous System Disorders Therapeutics Business (2015-2020)
  13.3.5 Janssen Pharmaceuticals Recent Development
13.4 Novartis
  13.4.1 Novartis Company Details
  13.4.2 Novartis Business Overview and Its Total Revenue
  13.4.3 Novartis Central Nervous System Disorders Therapeutics Introduction
  13.4.4 Novartis Revenue in Central Nervous System Disorders Therapeutics Business (2015-2020)
  13.4.5 Novartis Recent Development
13.5 Pfizer
  13.5.1 Pfizer Company Details
  13.5.2 Pfizer Business Overview and Its Total Revenue
  13.5.3 Pfizer Central Nervous System Disorders Therapeutics Introduction
  13.5.4 Pfizer Revenue in Central Nervous System Disorders Therapeutics Business (2015-2020)
  13.5.5 Pfizer Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Central Nervous System Disorders Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Central Nervous System Disorders Therapeutics Revenue
Table 3. Ranking of Global Top Central Nervous System Disorders Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Central Nervous System Disorders Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Depression
Table 6. Key Players of MS
Table 7. Key Players of bipolar disorder
Table 8. Key Players of schizophrenia
Table 9. Key Players of epilepsy
Table 10. Key Players of AD
Table 11. Key Players of Parkinson' s
Table 12. Key Players of others
Table 13. Global Central Nervous System Disorders Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Central Nervous System Disorders Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Central Nervous System Disorders Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Central Nervous System Disorders Therapeutics Market Share by Regions (2015-2020)
Table 17. Global Central Nervous System Disorders Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Central Nervous System Disorders Therapeutics Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Central Nervous System Disorders Therapeutics Market Growth Strategy
Table 23. Main Points Interviewed from Key Central Nervous System Disorders Therapeutics Players
Table 24. Global Central Nervous System Disorders Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 25. Global Central Nervous System Disorders Therapeutics Market Share by Players (2015-2020)
Table 26. Global Top Central Nervous System Disorders Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Central Nervous System Disorders Therapeutics as of 2019)
Table 27. Global Central Nervous System Disorders Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Central Nervous System Disorders Therapeutics Product Solution and Service
Table 30. Date of Enter into Central Nervous System Disorders Therapeutics Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Central Nervous System Disorders Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 33. Global Central Nervous System Disorders Therapeutics Market Size Share by Type (2015-2020)
Table 34. Global Central Nervous System Disorders Therapeutics Revenue Market Share by Type (2021-2026)
Table 35. Global Central Nervous System Disorders Therapeutics Market Size Share by Application (2015-2020)
Table 36. Global Central Nervous System Disorders Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 37. Global Central Nervous System Disorders Therapeutics Market Size Share by Application (2021-2026)
Table 38. North America Key Players Central Nervous System Disorders Therapeutics Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Central Nervous System Disorders Therapeutics Market Share (2019-2020)
Table 40. North America Central Nervous System Disorders Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 41. North America Central Nervous System Disorders Therapeutics Market Share by Type (2015-2020)
Table 42. North America Central Nervous System Disorders Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 43. North America Central Nervous System Disorders Therapeutics Market Share by Application (2015-2020)
Table 44. Europe Key Players Central Nervous System Disorders Therapeutics Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Central Nervous System Disorders Therapeutics Market Share (2019-2020)
Table 46. Europe Central Nervous System Disorders Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Central Nervous System Disorders Therapeutics Market Share by Type (2015-2020)
Table 48. Europe Central Nervous System Disorders Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Central Nervous System Disorders Therapeutics Market Share by Application (2015-2020)
Table 50. China Key Players Central Nervous System Disorders Therapeutics Revenue (2019-2020) (Million US$)
Table 51. China Key Players Central Nervous System Disorders Therapeutics Market Share (2019-2020)
Table 52. China Central Nervous System Disorders Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 53. China Central Nervous System Disorders Therapeutics Market Share by Type (2015-2020)
Table 54. China Central Nervous System Disorders Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 55. China Central Nervous System Disorders Therapeutics Market Share by Application (2015-2020)
Table 56. Japan Key Players Central Nervous System Disorders Therapeutics Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Central Nervous System Disorders Therapeutics Market Share (2019-2020)
Table 58. Japan Central Nervous System Disorders Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Central Nervous System Disorders Therapeutics Market Share by Type (2015-2020)
Table 60. Japan Central Nervous System Disorders Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Central Nervous System Disorders Therapeutics Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Central Nervous System Disorders Therapeutics Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Central Nervous System Disorders Therapeutics Market Share (2019-2020)
Table 64. Southeast Asia Central Nervous System Disorders Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Central Nervous System Disorders Therapeutics Market Share by Type (2015-2020)
Table 66. Southeast Asia Central Nervous System Disorders Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Central Nervous System Disorders Therapeutics Market Share by Application (2015-2020)
Table 68. India Key Players Central Nervous System Disorders Therapeutics Revenue (2019-2020) (Million US$)
Table 69. India Key Players Central Nervous System Disorders Therapeutics Market Share (2019-2020)
Table 70. India Central Nervous System Disorders Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 71. India Central Nervous System Disorders Therapeutics Market Share by Type (2015-2020)
Table 72. India Central Nervous System Disorders Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 73. India Central Nervous System Disorders Therapeutics Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Central Nervous System Disorders Therapeutics Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Central Nervous System Disorders Therapeutics Market Share (2019-2020)
Table 76. Central & South America Central Nervous System Disorders Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Central Nervous System Disorders Therapeutics Market Share by Type (2015-2020)
Table 78. Central & South America Central Nervous System Disorders Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Central Nervous System Disorders Therapeutics Market Share by Application (2015-2020)
Table 80. Eli Lilly Company Details
Table 81. Eli Lilly Business Overview
Table 82. Eli Lilly Product
Table 83. Eli Lilly Revenue in Central Nervous System Disorders Therapeutics Business (2015-2020) (Million US$)
Table 84. Eli Lilly Recent Development
Table 85. GlaxoSmithKline Company Details
Table 86. GlaxoSmithKline Business Overview
Table 87. GlaxoSmithKline Product
Table 88. GlaxoSmithKline Revenue in Central Nervous System Disorders Therapeutics Business (2015-2020) (Million US$)
Table 89. GlaxoSmithKline Recent Development
Table 90. Janssen Pharmaceuticals Company Details
Table 91. Janssen Pharmaceuticals Business Overview
Table 92. Janssen Pharmaceuticals Product
Table 93. Janssen Pharmaceuticals Revenue in Central Nervous System Disorders Therapeutics Business (2015-2020) (Million US$)
Table 94. Janssen Pharmaceuticals Recent Development
Table 95. Novartis Company Details
Table 96. Novartis Business Overview
Table 97. Novartis Product
Table 98. Novartis Revenue in Central Nervous System Disorders Therapeutics Business (2015-2020) (Million US$)
Table 99. Novartis Recent Development
Table 100. Pfizer Company Details
Table 101. Pfizer Business Overview
Table 102. Pfizer Product
Table 103. Pfizer Revenue in Central Nervous System Disorders Therapeutics Business (2015-2020) (Million US$)
Table 104. Pfizer Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Central Nervous System Disorders Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Depression Features
Figure 3. MS Features
Figure 4. bipolar disorder Features
Figure 5. schizophrenia Features
Figure 6. epilepsy Features
Figure 7. AD Features
Figure 8. Parkinson' s Features
Figure 9. others Features
Figure 10. Global Central Nervous System Disorders Therapeutics Market Share by Application: 2020 VS 2026
Figure 11. Clinicals Case Studies
Figure 12. Hospitials Case Studies
Figure 13. Central Nervous System Disorders Therapeutics Report Years Considered
Figure 14. Global Central Nervous System Disorders Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 15. Global Central Nervous System Disorders Therapeutics Market Share by Regions: 2020 VS 2026
Figure 16. Global Central Nervous System Disorders Therapeutics Market Share by Regions (2021-2026)
Figure 17. Porter's Five Forces Analysis
Figure 18. Global Central Nervous System Disorders Therapeutics Market Share by Players in 2019
Figure 19. Global Top Central Nervous System Disorders Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Central Nervous System Disorders Therapeutics as of 2019
Figure 20. The Top 10 and 5 Players Market Share by Central Nervous System Disorders Therapeutics Revenue in 2019
Figure 21. North America Central Nervous System Disorders Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Europe Central Nervous System Disorders Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. China Central Nervous System Disorders Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Japan Central Nervous System Disorders Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Southeast Asia Central Nervous System Disorders Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. India Central Nervous System Disorders Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Central & South America Central Nervous System Disorders Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Eli Lilly Revenue Growth Rate in Central Nervous System Disorders Therapeutics Business (2015-2020)
Figure 30. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. GlaxoSmithKline Revenue Growth Rate in Central Nervous System Disorders Therapeutics Business (2015-2020)
Figure 32. Janssen Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Janssen Pharmaceuticals Revenue Growth Rate in Central Nervous System Disorders Therapeutics Business (2015-2020)
Figure 34. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Novartis Revenue Growth Rate in Central Nervous System Disorders Therapeutics Business (2015-2020)
Figure 36. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Pfizer Revenue Growth Rate in Central Nervous System Disorders Therapeutics Business (2015-2020)
Figure 38. Bottom-up and Top-down Approaches for This Report
Figure 39. Data Triangulation
Figure 40. Key Executives Interviewed